Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Shasha Lu, Yu Xu, Qitian Mu, Lihong Cao, Jian Chen, Zhijuan Zhu, Yinjun Lou, Haitao Meng, Wenbin Qian, Hongyan Tong, Wenyuan Mai, Jian Huang, Wenjuan Yu, Xiaoying Zhao & Jie Jin. (2015) The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy. Leukemia & Lymphoma 56:4, pages 1027-1032.
Read now
Read now
Articles from other publishers (14)
Ying Liu, Wai I. Ho, Feiwen Deng, Siwei Peng, Wan Yee Lau & Huanwei Chen. (2021) Entecavir Monotherapy Prevents Hepatitis B Virus Recurrence After Liver Transplant for Chronic Hepatitis B Patients: A Long-Term Retrospective Study. Transplantation Proceedings 53:5, pages 1700-1706.
Crossref
Crossref
Jun Chen, Shu-Shan Zhao, Xiao-xiao Liu, Ze-Bing Huang & Yan Huang. (2017) Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis. Clinical Therapeutics 39:9, pages 1870-1880.
Crossref
Crossref
Xi Yang, Zhiyuan Ma, Sisi Zhou, Yayun Weng, Hongmei Lei, Su Zeng, Liping Li & Huidi Jiang. (2016) Multiple Drug Transporters Are Involved in Renal Secretion of Entecavir. Antimicrobial Agents and Chemotherapy 60:10, pages 6260-6270.
Crossref
Crossref
Ma Min, Jiang Xingjun, Wang Xueding, Zou Hao, Yang Weiqing, Zhang Yuanyuan, Peng Changrong, Li Zicheng, Yang Jing, Du Quan & Ma Menglin. (2016) Synthesis and Quantitative Structure-activity Relationships Study for Arylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication. Chemical Biology & Drug Design 88:3, pages 451-459.
Crossref
Crossref
Jing Yang, Min Ma, Xue-Ding Wang, Xing-Jun Jiang, Yuan-Yuan Zhang, Wei-Qing Yang, Zi-Cheng Li, Xi-Hong Wang, Bin Yang & Meng-Lin Ma. (2015) Synthesis and quantitative structure–activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication. European Journal of Medicinal Chemistry 99, pages 82-91.
Crossref
Crossref
Zhi-Feng Xi & Qiang Xia. (2015) Recent advances in prevention of hepatitis B recurrence after liver transplantation. World Journal of Gastroenterology 21:3, pages 829.
Crossref
Crossref
Maria Buti, Rosa M. Morillas, Juan Pérez, Martín Prieto, Ricard Solà, Antonio Palau, Moisés Diago, Lucía Bonet, Adolfo Gallego, Javier García-Samaniego, Milagros Testillano, Manuel Rodríguez, Gregorio Castellano, María L. Gutiérrez, Manuel Delgado, Antoni Mas, Manuel Romero-Gómez, José L. Calleja, Agustina González-Guirado, Juan I. Arenas, Luisa García-Buey, Raúl Andrade & Ana Gila. (2015) Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities. European Journal of Gastroenterology & Hepatology 27:1, pages 46-54.
Crossref
Crossref
Ze-Bing Huang, Shu-Shan Zhao, Yan Huang, Xia-Hong Dai, Rong-Rong Zhou, Pan-Pan Yi, Ruo-Chan Chen, Wen-Ting Li, Bao-Xin Zhang, Ning Li & Xue-Gong Fan. (2013) Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Clinical Therapeutics 35:12, pages 1997-2006.
Crossref
Crossref
S. Amini-Bavil-Olyaee, U. Herbers, T. Luedde, C. Trautwein & F. Tacke. (2011) Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains. Journal of Viral Hepatitis 18:11, pages 804-814.
Crossref
Crossref
Yu Xuan Koo, Matthew Tay, Yii Ean Teh, David Teng, Daniel S. W. Tan, Iain B. H. Tan, David W. M. Tai, Richard Quek, Miriam Tao & Soon Thye Lim. (2011) Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis. Annals of Hematology 90:10, pages 1219-1223.
Crossref
Crossref
Peiyuan Wang, Devan Naduthambi, Ralph T. Mosley, Congrong Niu, Phillip A. Furman, Michael J. Otto & Michael J. Sofia. (2011) Phenylpropenamide derivatives: Anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs. Bioorganic & Medicinal Chemistry Letters 21:15, pages 4642-4647.
Crossref
Crossref
Li-Chun Wang, En-Qiang Chen, Jing Cao, Li Liu, Li Zheng, Da-Jiang Li, Lu Xu, Xue-Zhong Lei, Cong liu & Hong Tang. (2011) De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients. Hepatology International 5:2, pages 671-676.
Crossref
Crossref
Zhiliang Lv, Chunquan Sheng, Tiantian Wang, Yikai Zhang, Jia Liu, Jilu Feng, Hailing Sun, Hanyu Zhong, Chunjuan Niu & Ke Li. (2009) Design, Synthesis, and Antihepatitis B Virus Activities of Novel 2-Pyridone Derivatives. Journal of Medicinal Chemistry 53:2, pages 660-668.
Crossref
Crossref
Raymond Liang. (2009) How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood 113:14, pages 3147-3153.
Crossref
Crossref